We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Predictive Factors for the Development of Osteonecrosis After the Treatment of the Developmental Dislocated Hip

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01133938
First Posted: May 31, 2010
Last Update Posted: June 3, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Orthopedic Hospital Vienna Speising
  Purpose
Several risk factors for the development of osteonecrosis of the femoral head following treatment of developmental dislocated hip have been reported. The need for further research with a large-enough sample size including statistical adjustment of confounders was demanded. The purpose of the present study was to find reliable predictors of osteonecrosis in patients managed for developmental dislocation of the hip and to evaluate if delayed treatment increased the risk of residual acetabular dysplasia requiring secondary surgeries.

Condition
Predictors of Osteonecrosis of the Femoral Head After Treatment of the Dislocated Hip

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Predictive Factors for the Development of Osteonecrosis After the Treatment of the Developmental Dislocated Hip. A Comparison of Early Open Reduction Versus Late Open Reduction With Combined Pemberton and Femoral Osteotomies

Resource links provided by NLM:


Further study details as provided by Orthopedic Hospital Vienna Speising:

Primary Outcome Measures:
  • Osteonecrosis of the femoral head

Secondary Outcome Measures:
  • Secondary reconstructive procedures due to residual acetabular dysplasia

Enrollment: 79
Study Start Date: January 2009
Study Completion Date: May 2010
Primary Completion Date: February 2010 (Final data collection date for primary outcome measure)
Groups/Cohorts
Closed reduction < 12 months of age
Open reduction < 12 months of age
Open reduction with concomitant osteotomies > 12 months fo age

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   1 Month to 15 Years   (Child)
Sexes Eligible for Study:   All
Sampling Method:   Probability Sample
Study Population
Consecutive series of patients hospitalized because of developmental dislocated hip between 1198 and February 2007
Criteria

Inclusion Criteria:

  • Follow-up > 3 years

Exclusion Criteria:

  • teratological hip dislocation
  • neuromuscular disease
  • previous open reduction at another medical institution
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01133938


Locations
Austria
Orthopedic Hospital Vienna Speising
Vienna, Austria, 1130
Sponsors and Collaborators
Orthopedic Hospital Vienna Speising
  More Information

Responsible Party: Orthopedic Hospital Vienna Speising
ClinicalTrials.gov Identifier: NCT01133938     History of Changes
Other Study ID Numbers: OR-27052010
First Submitted: May 28, 2010
First Posted: May 31, 2010
Last Update Posted: June 3, 2010
Last Verified: May 2010

Additional relevant MeSH terms:
Osteonecrosis
Joint Dislocations
Hip Dislocation
Bone Diseases
Musculoskeletal Diseases
Necrosis
Pathologic Processes
Wounds and Injuries
Hip Injuries